Home/Eternygen/Dr. Christian Schetter
DC

Dr. Christian Schetter

Chairman of the Board

Eternygen

Eternygen Pipeline

DrugIndicationPhase
SLC13A5 Inhibitor ProgramMetabolic Diseases (NAFLD/NASH, CKD, Diabetes, Obesity)Pre-clinical
SLC13A5 Modulator ProgramAge-Related Bone Loss / OsteoporosisPre-clinical